This Jacksonville company's stock is surging as the market sees there's "no competitor"

TapImmune Inc. stock has blossomed in the month since it announced it will merge with a company producing similar cancer-fighting treatments, begin a strategic alliance with Baylor College of Medicine and move to Houston. The stock has more than tripled since the announcement and rose more than 18 percent Friday. TapImmune (Nasdaq: TPIV) develops cancer-fighting immunotherapies that target breast and ovarian cancers. It is merging with Marker Therapeutics Inc., which develops similar therapies,…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news